First day of dealings

RNS Number : 6690Y
Impact Healthcare REIT PLC
07 March 2017
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member states of the European Economic Area (other than the United Kingdom and Ireland), Canada, Australia, Japan or South Africa.

 

7 March 2017

Impact Healthcare REIT plc

(the "Company")

First day of dealings

Impact Healthcare REIT plc is pleased to announce the admission and commencement of dealings in its Ordinary Shares at 8.00 a.m. today on the specialist fund segment of the main market of the London Stock Exchange ("Admission"). The Ordinary Shares will trade under the TIDM: IHR.

 

The total number of Ordinary Shares in the Company in issue immediately following Admission is 146,172,360, each with equal voting rights.  This total voting rights figure can be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in the Company under the Disclosure and Transparency Rules of the Financial Conduct Authority.

 

An additional 14,000,000 Ordinary Shares will be admitted to trading on the specialist fund segment of the main market of the London Stock Exchange on Completion of the acquisition of the Seed Portfolio, as outlined in the Prospectus

 

Terms used in this announcement shall, unless the context otherwise requires, bear the meanings given to them in the announcement published by the Company on 24 January 2017.

 

For further information, please contact:

 

Impact Health Partners LLP

Mahesh Patel

Andrew Cowley

 

via Newgate Communications

Winterflood Securities Limited

Tel: 020 3100 0000

Joe Winkley

Neil Langford

 

 

Newgate Communications

James Benjamin

Zoë Pocock

Lydia Thompson

 

Tel: 020 7680 6550

Email: impact@newgatecomms.com

 

Notes:

The Company intends to become a real estate investment trust ("REIT") and provide shareholders with an attractive return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified portfolio of healthcare real estate opportunities. The Company will acquire, own, lease, renovate, extend and redevelop high quality healthcare real estate assets in the UK and lease those assets primarily to healthcare operators providing residential healthcare services under full repairing and insuring leases.

 

The net proceeds of the Issue will be used to acquire the Seed Portfolio, which will comprise up to 58 residential care homes offering 2,558 beds and lease the Seed Portfolio to the Initial Tenants, in each case for an initial term of 20 years with an option to extend for two further 10 year periods. The leases are subject to annual uplifts based on increases in the UK retail prices index (subject to a cap and floor).

 

The Company is targeting the payment of dividends for the first 12 months from Admission which equate to a yield of 6 per cent. per annum on the Issue Price, on an ungeared basis and payable in quarterly instalments. The Company is also seeking to grow the dividend over time.

 

The Company and its Investment Adviser believe that residential healthcare is a significant investment opportunity in the UK, owing to both increasing demand for various forms of care from a growing and ageing population and the current reduction in the supply of suitable assets for providing that care. A well-capitalised landlord like the Company, with an experienced investment adviser, should be well positioned to deliver attractive returns to investors, while also providing stability and a commitment to enhance homes wherever possible to their residents.

 

Further information on Impact Healthcare REIT is available at www.impactreit.uk 

 

IMPORTANT INFORMATION

This announcement has been prepared by, and is the sole responsibility of, the Directors of Impact Healthcare REIT plc.

This announcement does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to subscribe for, any shares in the Company in any jurisdiction nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with or act as any inducement to enter into, any contract therefor. 

This announcement may not be published, distributed or transmitted by any means or media, directly or indirectly, in whole or in part, in or into the United States.  This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States.  The securities mentioned herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "US Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States and will not be offered, sold, exercised, resold, transferred or delivered, directly or indirectly, in or into the United States or to, or for the account or benefit of, any US person (as defined under Regulation S under the US Securities Act).  The Company has not been, and will not be, registered under the U.S. Investment Company Act of 1940, as amended.

Neither this announcement nor any copy of it may be: (i) taken or transmitted into or distributed in any member state of the European Economic Area (other than the United Kingdom and Ireland), Canada, Australia or the Republic of South Africa or to any resident thereof, or (ii) taken or transmitted into or distributed in Japan or to any resident thereof. Any failure to comply with these restrictions may constitute a violation of the securities laws or the laws of any such jurisdiction. The distribution of this announcement in other jurisdictions may be restricted by law and the persons into whose possession this document comes should inform themselves about, and observe, any such restrictions.

Winterflood Securities Limited, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting only for the Company in connection with the matters described in this announcement and is not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Winterflood Securities Limited or advice to any other person in relation to the matters contained herein. Neither Winterflood Securities Limited nor any of its directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for this announcement, its contents or otherwise in connection with it or any other information relating to the Company, whether written, oral or in a visual or electronic format.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISUGUCPWUPMGMQ
UK 100

Latest directors dealings